Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Invion ( (AU:IVX) ) has provided an announcement.
Invion Limited has announced the application for quotation of new securities on the Australian Securities Exchange (ASX). This move involves the issuance of 206 ordinary fully paid securities, which were converted from options or other convertible securities. This development may enhance Invion’s market presence and provide additional resources for its ongoing research and development efforts.
More about Invion
Invion Limited operates in the biotechnology industry, focusing on the development of treatments for chronic inflammatory diseases. The company is primarily engaged in research and development activities aimed at creating innovative therapeutic solutions.
Average Trading Volume: 124,793
Technical Sentiment Signal: Sell
Current Market Cap: A$7.97M
See more data about IVX stock on TipRanks’ Stock Analysis page.

